Renjie Ruan
Overview
Explore the profile of Renjie Ruan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ruan R, Zhang P, Lambers H, Xie W, Zhang Z, Xie S, et al.
Sci Total Environ
. 2024 Nov;
956:177379.
PMID: 39505045
Biochar application emerges as a valuable soil management strategy for enhancing crop yield; however, the mechanisms underlying the relationships between soil and plants remain unclear after biochar application. In this...
2.
Ma D, Fu C, Li F, Ruan R, Lin Y, Li X, et al.
Bioact Mater
. 2024 Jun;
39:521-543.
PMID: 38883317
Spinal cord injury (SCI) often results in irreversible loss of sensory and motor functions, and most SCIs are incurable with current medical practice. One of the hardest challenges in treating...
3.
Gong C, Wang J, Tang F, Tong D, Wang Z, Zhou Z, et al.
ACS Appl Mater Interfaces
. 2024 Feb;
16(7):8538-8553.
PMID: 38343191
Large osseous void, postsurgical neoplastic recurrence, and slow bone-cartilage repair rate raise an imperative need to develop functional scaffold in clinical osteosarcoma treatment. Herein, a bionic bilayer scaffold constituting croconaine...
4.
Ruan R, Chen S, Su J, Liu N, Feng H, Xiao P, et al.
Adv Healthc Mater
. 2023 Dec;
13(5):e2302591.
PMID: 38085119
Nowadays, cardiovascular and cerebrovascular diseases caused by venous thromboembolism become main causes of mortality around the world. The current thrombolytic strategies in clinics are confined primarily due to poor penetration...
5.
Ruan R, Liu Y, Zhang X
BMC Cardiovasc Disord
. 2023 Nov;
23(1):563.
PMID: 37974073
Background: Coronary heart disease (CHD) is a major complication of type 2 diabetes mellitus (T2DM), which causes an adverse prognosis. There is an urgent need to explore effective biomarkers to...
6.
Ruan R, Liu X, Zhang Y, Tang M, He B, Zhang Q, et al.
J Am Heart Assoc
. 2023 Jun;
12(13):e028921.
PMID: 37366108
Background Population growth, aging, and major alterations in epidemiologic trends inadvertently modulate the status of rheumatic heart disease (RHD) epidemiology. This investigation predicted RHD burden pattern and temporal trends to...
7.
Qian J, Su L, He J, Ruan R, Wang J, Wang Z, et al.
ACS Nano
. 2022 Sep;
16(10):16880-16897.
PMID: 36136320
Most treatments for spinal cancer are accompanied by serious side effects including subsequent tumor recurrence, spinal cord compression, and tissue adhesion, thus a highly effective treatment is crucial for preserving...
8.
Zhang J, Tong D, Song H, Ruan R, Sun Y, Lin Y, et al.
Adv Mater
. 2022 Jul;
34(36):e2202044.
PMID: 35785450
Engineering a proper immune response following biomaterial implantation is essential to bone tissue regeneration. Herein, a biomimetically hierarchical scaffold composed of deferoxamine@poly(ε-caprolactone) nanoparticles (DFO@PCL NPs), manganese carbonyl (MnCO) nanosheets, gelatin...
9.
Ma Y, Lan T, Wang X, Ruan R, Cao Y, Dai J, et al.
Opt Express
. 2022 Mar;
30(6):9892-9903.
PMID: 35299402
In this paper, phase-locking dynamics of 2D VCSEL hexagonal array with an integrated Talbot cavity are numerically investigated based on rate equations aiming at achieving high brightness output. The processes...
10.
Zhang J, Lin Y, Lin Z, Wei Q, Qian J, Ruan R, et al.
Adv Sci (Weinh)
. 2021 Dec;
9(5):e2103444.
PMID: 34927373
Cancer immunotherapy has achieved promising clinical progress over the recent years for its potential to treat metastatic tumors and inhibit their recurrences effectively. However, low patient response rates and dose-limiting...